Significance of Evaluating Tumor Markers in the Oncological Criteria for Resectability in Hepatocellular Carcinoma
AFP and DCP provide independent prognostic information beyond the oncological resectability criteria. Incorporating tumor markers may refine risk stratification and optimize multidisciplinary treatment strategies for HCC.
Authors
- Ryo Ashida
- Katsuhiko Uesaka (ORCID: https://orcid.org/0000-0002-9983-1730)
- Hideyuki Dei (ORCID: https://orcid.org/0000-0002-5091-5036)
- Yukiyasu Okamura (ORCID: https://orcid.org/0000-0003-3384-2709)
- Teiichi Sugiura (ORCID: https://orcid.org/0000-0001-7163-4084)
- Rui Sato (ORCID: https://orcid.org/0000-0003-0230-7471)
- Yoshiyasu Kato (ORCID: https://orcid.org/0000-0002-2203-256X)
- Shimpei Otsuka (ORCID: https://orcid.org/0000-0002-2450-3011)
- Yuya Miura (ORCID: https://orcid.org/0000-0003-0461-4109)
- Katsuhisa Ohgi (ORCID: https://orcid.org/0000-0003-1647-1117)
Institutions
- Nihon University (JP)
- Shizuoka Cancer Center (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1111/hepr.70096
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00